CL
JAZZ icon

Choreo LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Choreo LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$561K Buy
2,968
+85
+3% +$14.9K 0.01% 875
2025
Q4 		$492K Buy
+2,883
New +$442K 0.01% 930
2025
Q2 		– Sell
-2,423
Closed -$301K – 1567
2025
Q1 		$301K Sell
2,423
-531
-18% -$69.3K ﹤0.01% 1087
2024
Q4 		$363K Buy
2,954
+1,087
+58% +$128K 0.01% 1076
2024
Q3 		$204K Buy
+1,867
New +$205K ﹤0.01% 1460

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Choreo LLC's JAZZ Position: Q1 2026 in Review

Choreo LLC increased its Jazz Pharmaceuticals (JAZZ) stake by 2.9% in Q1 2026, buying an estimated $14.9K and bringing the position to 2,968 shares worth $561K. The position accounts for 0.01% of the portfolio, ranked #875.

Choreo LLC first reported a position in JAZZ in Q3 2024 and has held it in 5 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Choreo LLC held 2,968 shares of Jazz Pharmaceuticals worth $561K as of Q1 2026.
  • Choreo LLC bought 85 Jazz Pharmaceuticals shares in Q1 2026, an estimated $14.9K.
  • Jazz Pharmaceuticals made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #875 holding.
  • Choreo LLC first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.